Vigilant Biosciences, Inc

Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilantTM OraFusion System aids clinicians with identifying patients at risk for oral cancers. It is simple, accurate and cost-effective, empowering healthcare practitioners to improve lives through earlier intervention. The BeVigilantTM OraFusion System, the first and only technology that measures tumor-initiating and stem cell associated biomarkers markers clinically validated to be associated with oral cancer was developed to aid clinicians in the early detection of oral cancer. The point-of-care BeVigilantTM OraFusion System uses a simple collection method that is easy to administer and non-invasive for the patient. The test has the potential to benefit adults at risk of oral cancer, with particular emphasis on high-risk populations (i.e., current and former tobacco users, those who consume excessive alcohol, and people with human papillomavi...